IFF - Leadership updates

Deborah Borg Brings 25+ Years of Corporate Leadership to Global Manufacturing Leader Mativ Holdings, Inc. (NYSE:MATV) announced today the appointment of Deborah Borg to its Board of Directors, effective immediately. In her role on the Mativ Board of Directors, Borg will serve on the Company's Compensation Committee and Nominating & Governance Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124104625/en/Deborah Borg, Mativ Board of Directors Borg is currently the Executive Vice President, Chief People & Culture Officer at International Flavors & Fragrances Inc. (NYSE:IFF), a global leader in food, beverage, health, b

IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Brett Icahn and Richard Mulligan, Ph.D., to its board of directors, effective Oct. 20. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022380951/en/Brett Icahn (Photo: IFF) These appointments follow the company's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Icahn serves as the Icahn designee to the IFF board, replacing Vincent Intrieri, and Mulligan joined as the mutually agreed independent director, replacing Margarita Paláu-Hernández. Intrieri and Paláu-Her

In the news release, Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors, issued 10-Oct-2025 by National Association of Corporate Directors over PR Newswire, we are advised by the company that the third paragraph, the end of the last line, should read "IBM Business Transformation Services" instead of "IBM Consulting Business Transformation Services" as originally issued inadvertently. The complete, corrected release follows: Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors Seasoned executives bring deep expertise in innovation, governance, and business to strengthen NACD's leadership board excellence WASHINGTON, Oct. 10, 2025 /PRNewswire/ -- Th

Seasoned executives bring deep expertise in innovation, governance, and business to strengthen NACD's leadership board excellence WASHINGTON, Oct. 10, 2025 /PRNewswire/ -- The National Association of Corporate Directors® (NACD®) today announced the appointment of Jesús Mantas, recently retired Global Leader of IBM Business Consulting, and Wes Bricker, Global Assurance Leader at PwC, to its board of directors, effective immediately. The appointments bring to NACD a wealth of experience spanning technology, innovation, assurance, governance and capital markets — further strengthening the association's ability to guide directors as they navigate today's rapidly evolving business landscape. Mant

IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Paul J. Fribourg and Jesus B. Mantas to its board of directors, effective immediately. These appointments bring extensive international leadership experience, and industry and strategic insight to IFF as the company continues to advance its innovation agenda and strengthen its market position. "I am delighted that Paul and Jesus are joining the IFF board," said Kevin O'Byrne, chair of the IFF board. "They bring a strong combination of digital innovation, global market insight and operational excellence. Their experience, leadership and vision will help guide

IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Gina Drosos to its board of directors, effective June 16. Drosos brings more than 30 years of executive leadership experience across the retail, consumer goods, beauty and health care industries. "We are very pleased to welcome Gina to the IFF board," said Kevin O'Byrne, chair of the board. "Gina brings extensive relevant experience, deep consumer insights and a proven ability to drive innovation and lead with purpose, which aligns with our long-term strategy to deliver sustainable growth and value creation for all stakeholders." Drosos most recently served

Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep

NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re

IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in

International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.7 B   $(2.6) B   $(10.21)   $461 M   17.1%   $0.72 Full Year 2023 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- IFF today announced the promotion of three perfumers to vice president perfumers: Patricia "Patty" Hidalgo, Joa Kim and Birgit Sijbrands. Patricia "Patty" Hidalgo — a beacon of creativity and innovation in the fragrance industry with a storied career spanning three decades — began her journey at IFF by joining through the Fragrance Resources acquisition in 2017. A scholar in biology and chemistry, her technical skills propelled her from a laboratory technician to a towering strength in perfumery creation, where she has since been craftin

IFF (NYSE:IFF) today announced the appointment of J. Erik Fyrwald to succeed Frank Clyburn as Chief Executive Officer and member of the IFF Board of Directors, effective Feb. 6, 2024. Clyburn will work closely with Fyrwald to ensure a seamless transition, remaining with IFF until March 31, 2024, and further serving in an advisory capacity through December 2024. Fyrwald brings to IFF more than four decades of executive and operational experience driving innovation and profitable, sustainable growth at leading corporations in the nutrition, agriculture and chemicals industries. He most recently served as Chief Executive Officer of Syngenta, where he spearheaded the strategy that ultimately

International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.8 B   $(5) M   $0.01   $441 M   15.5%   $0.97 Full Year 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $12.4 B   $(1.

IFF (NYSE:IFF) today announced the appointment of Gary Hu to the Company's Board of Directors, effective Feb. 1, 2023. Hu, a portfolio manager at Icahn Capital, will be appointed to the Board's Audit and Transaction Committees. In connection with this appointment, IFF has entered into a cooperation agreement with Icahn Capital LP and its affiliates. "On behalf of the IFF Board of Directors, I would like to welcome Gary to the Board," said Dale Morrison, chairman of IFF's Board of Directors. "We expect that Gary's board experience – coupled with his financial and investment expertise – will prove a solid addition to our Board. We look forward to working alongside him as we continue to execu

IFF (NYSE:IFF) today announced the appointment of accomplished consumer products industry executive Dawn Willoughby to the Company's Board of Directors as an independent director, effective Feb. 1, 2023. Willoughby, who most recently served as executive vice president and chief operating officer of The Clorox Company, brings an impressive track record of driving sustainable, profitable growth with a focus on innovation and sustainability for global consumer businesses. "We are thrilled to welcome Dawn to the IFF Board as we continue to evolve our Board consistent with the plans announced in our December Investor Day, and prioritize the addition of senior executives with the most relevant s

NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a leading global data analytics and digital operations and solutions company, today announced that Andreas Fibig, a seasoned global executive with a strong record of innovation across industries and geographies, has been appointed to EXL's Board of Directors as an independent director effective Jan. 10, 2023. Fibig will be a member of the Board's Audit and Nominating and Governance Committees. "Andreas is a distinguished global business leader with more than 25 years of international health care, pharmaceutical, and consumer industry experience," said Vikram S. Pandit, Chairman of the Board of EXL. "We lo

Nicolas Mirzayantz to depart IFF following career of industry-defining accomplishments IFF (NYSE:IFF) today announced that Nicolas Mirzayantz, president of IFF's Nourish division, will leave the Company following a successful 34+ year tenure, effective Dec. 31, 2022. Upon his departure, IFF CEO Frank Clyburn will lead IFF's current Nourish division until a replacement is named. Mirzayantz had an illustrious career in which he served in critical leadership roles across the organization. He first joined IFF's Creative Center in Paris in 1988, and later served as regional manager of North America and divisional CEO of Scent, where he transformed IFF's Scent division into a global leader. Dur

IFF (NYSE:IFF) today announced the next phase of its strategic transformation by previewing its refreshed strategic plan and new operating model, developed through an extensive assessment with the Company's senior leadership, customers, investors and key partners. At its Investor Day on Dec. 7, 2022, IFF management will provide additional commentary on the following financial and strategic initiatives: Growth-Focused Strategy: IFF shared a new strategic framework, positioning the Company to Do What Matters Most, driving sustained profitable growth, deepening its commitment to customers, and embedding Environmental, Social and Governance (ESG+) priorities across the entire enterprise. E

IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $3.1 B   $(2.0) B   $(8.60)   $612 M   20.0%   $1.36 First Nine Months 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $9.6 B   $(1.6) B   $(7.2

AUSTIN, TX / ACCESSWIRE / September 6, 2022 / Thermon Group Holdings, Inc. (NYSE:THR) ("Thermon"), a global leader in industrial process heating solutions, today announced the appointment of Dr. Angela Strzelecki, President of the Pharmaceutical Solutions Division of International Flavors & Fragrances (NYSE:IFF), to its board of directors.John Nesser, Chairman of the board, said, "We are delighted that Angela has accepted our invitation to join the Thermon board of directors. She brings a wealth of knowledge and relevant experience to our board, and her recruitment adds further gender diversity to our board and augments our long-term board succession plans. In addition to bringing a proven t

International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $3.3 B   $130 M   $0.43   $700 M   21.2%   $1.54 First Six Months 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $6.5 B   $415 M

Company adjusts organizational structure in the Nourish division to enhance customer experience NEW YORK, July 5, 2022 /PRNewswire/ -- IFF (NYSE:IFF) today announced that Nicolas Gebara has been named senior vice president, Commercial and Flavors, Nourish, effective July 1, 2022. In his 23 years at IFF, Gebara has held various roles, most recently serving as vice president, North America for Nourish. In this newly created role, Gebara will streamline flavors and global sales across the division's expanded portfolio, delivering product designs finely tuned to changing consumer

International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the first quarter ended March 31, 2022. First Quarter 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $3.2 B   $285 M   $0.96   $702 M   21.8%   $1.69 Management Commentary "We are pleased with our strong start to 2022 led by broad-based growth across our entire portfolio," said IFF CEO Frank Clyburn. "Our pricing actions, in combination with our diligent focus on cost discipline, have helped o

IFF (NYSE:IFF) today announced the appointment of Barry A. Bruno to the Company's Board of Directors as an independent director, effective February 8, 2022. "We are pleased to welcome Barry to the IFF Board," said Ed Breen, IFF Lead Director. "Barry's leadership experience and track record with innovative, global consumer brands and deep international experience will benefit IFF's shareholders, employees and customers as IFF executes its strategic and operating priorities." "I am honored to join IFF's Board at this moment of great opportunity for the Company," said Mr. Bruno. "IFF is an innovative, customer-centric leader in solutions with global reach and an impressive portfolio, and I l

IFF (NYSE:IFF) today announced the appointment of Frank Clyburn, an accomplished leader and operational executive, to succeed Andreas Fibig as Chief Executive Officer and a member of the IFF Board of Directors, effective February 14, 2022. Mr. Clyburn joins IFF from Merck & Co. (Merck), where he currently serves as Executive Vice President and President of Human Health and today has full P&L responsibility for nearly 90% of Merck's $48 billion business. He brings extensive experience leading complex global businesses and executing with exceptional operating discipline. Mr. Clyburn has an in-depth understanding of R&D, extensive integration and M&A experience and a unique ability to connect

IFF (NYSE:IFF) today announced that Andreas Fibig, IFF's Chairman and Chief Executive Officer, plans to retire after a 10-year tenure with the company and more than seven years as IFF's Chairman and CEO. The Board of Directors is evaluating candidates to succeed Mr. Fibig as CEO with the support of a leading executive search firm. Mr. Fibig looks forward to continuing in his role as Chairman and CEO until a successor is named, which is expected by early 2022, and he has agreed to stay on for a period of time to support a seamless transition. At the time of his retirement, Mr. Fibig will also step down from IFF's Board of Directors. "Over the past several years, Andreas has successfully led

Provides Updated Financial Guidance for Full Year 2021 IFF (NYSE:IFF) today announced that Glenn Richter, an accomplished financial executive with nearly three decades of experience overseeing finance and corporate strategy for multinational companies, has been appointed Executive Vice President and Chief Financial Officer, effective September 27, 2021. Mr. Richter was most recently Chief Financial Officer of TIAA, a leading global provider of financial services with $1.3 trillion in assets under management. He succeeds Rustom Jilla, who will be leaving the Company following a period of transition. With this appointment, Mr. Richter becomes a member of IFF's Executive Committee and will be

Christophe de Villeplee to Assume the Role of President, Scent IFF (NYSE:IFF) today announced that Nicolas Mirzayantz, current President, Scent, has been appointed President of IFF's Nourish division, effective September 1, 2021. Mr. Mirzayantz will succeed Kathy Fortmann, current President, Nourish, who has decided to pursue other opportunities outside of IFF. IFF veteran and current President, Global Consumer Fragrances, Christophe de Villeplee, will assume transition into the role of President, Scent. "We could not be more pleased to have Nicolas lead our Nourish division," said IFF Chairman and CEO, Andreas Fibig. "Nicolas is joining a Nourish division with a tremendous opportunity t

TORONTO, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Mr. Donald G. Lang, Executive Chairman of CCL Industries Inc. (“CCL” or “the Company”) (TSX:CCL.A) (TSX:CCL.B), a world leader in specialty label, security and packaging solutions for global corporations, government institutions, small businesses and consumers, announced the appointment of Ms. Linda A. Cash and Dr. Susana Suarez-Gonzalez to the Board of Directors and the retirement of Ms. Mandy J. Shapansky from the Board of Directors. Ms. Cash has had a distinguished 36-year career as a senior executive with extensive global manufacturing and operations experience in the automotive industry. Ms. Cash joined Ford Motor Company (NYSE: F) in

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) (TASE: IFF) today announced a preview of its long-term outlook including three-year financial targets; confirmed cost and revenue synergy expectations based on the extensive integration work performed over the last year; and announced the expected members of the Board of Directors for the new IFF following the completion of the Company’s combination with DuPont’s Nutrition & Biosciences business (N&B). IFF expects to close the transaction on February 1, 2021. The new IFF will lead the evolution of the global value chain for consumer goods and commercial products with unmatched scale, R&D capabilities and portfolio strength. The Company w

WILMINGTON, Del., Dec. 31, 2020 /PRNewswire/ -- DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ("N&B") common stock. The exchange offer is part of DuPont's previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) ("IFF"). The exchange offer is designed to permit DuPont stockholders to exchange all or a portion of their shares of DuPont common stock for shares of N&B common stock (which will convert into shares of IFF common stock) at a discount of 7 percent to the per sh